PTM Bio

PTM BIO – Specialist in PTM Antibodies and Proteomics Solutions

PTM BIO is a leading innovator in post-translational modification (PTM) research, offering a unique combination of proprietary PTM reagents, cutting-edge mass spectrometry expertise, and advanced bioinformatics tools. These integrated solutions are designed to support academic and pharmaceutical researchers in uncovering new insights into protein function and regulation.

With a portfolio of PTM antibodies covering over 30 distinct modification types, PTM BIO has pioneered the development of several first-in-class antibodies, including:

• Lysine D-lactylation (2024)
• L-lactylation (2019)
• β-hydroxybutyrylation (2016)
• Succinylation (2011)

These antibodies have played a key role in identifying novel histone marks and expanding the understanding of epigenetic regulation.

The PTMab® product line includes:

• Primary Antibodies – including pan PTM Antibodies, histone and histone modification antibodies, organelle marker antibodies, loading controls, epitope tag antibodies, and more.
• Custom Antibodies
• Secondary antibodies
• IVD Raw Materials

PTM BIO also offers comprehensive proteomics services, including general proteomics, PTM profiling, Spatial Proteomics, and Single-Cell Proteomics, helping researchers generate high-quality, reproducible data